Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals & Medical Research Mega (1.0tn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (589.5bn) -1–5 -$1M–$10M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals & Medical Research Mega (429.6bn) 0 No activity — 0–15%
Healthcare Services Mega (377.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (326.2bn) 0 No activity — —
Pharmaceuticals & Medical Research Mega (309.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mega (290.1bn) -1–5 -$1M–$10M -0–15% 0–15%
CH Novartis AG (NOVN)
Pharmaceuticals & Medical Research Mega (287.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals & Medical Research Large (179.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (167.0bn) 0 No activity — 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals & Medical Research Large (164.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (155.9bn) 0 No activity — 0–15%
Healthcare Services Large (154.2bn) 1–5 $1M–$10M 0–15% 0–15%
Healthcare Services Large (150.4bn) 0 No activity — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals & Medical Research Large (146.5bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Large (130.0bn) -1–5 -$100M+ -0–15% 0–15%
US Stryker Corp (SYK)
Healthcare Services Large (120.0bn) -1–5 -$10M–$100M -0–15% 0–15%
US Danaher Corp (DHR)
Healthcare Services Large (116.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (115.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (112.9bn) 0 No activity — 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals & Medical Research Large (107.6bn) 0 No activity — 0–15%
Healthcare Services Large (107.4bn) 0 No activity — 0–15%
GB GSK plc (GSK)
Pharmaceuticals & Medical Research Large (101.7bn) 11–20 $100K–$1M 0–15% 0–15%
Healthcare Services Large (97.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (96.7bn) 0 No activity — 15–50%
Healthcare Services Large (90.8bn) -1–5 -$100K–$1M -0–15% 0–15%
AU CSL Ltd (CSL)
Pharmaceuticals & Medical Research Large (90.6bn) 0 No activity — 0–15%
US Celgene Corp (CELG)
Pharmaceuticals & Medical Research Large (77.0bn) 0 No activity — —
Pharmaceuticals & Medical Research Large (73.5bn) 0 No activity — 0–15%
Healthcare Services Large (72.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (67.3bn) 1–5 $100K–$1M 0–15% 0–15%
US Medline Inc (MDLN)
Healthcare Services Large (65.3bn) -1–5 -$100M+ -15–50% 0–15%
US Allergan plc (AGN)
Pharmaceuticals & Medical Research Large (63.7bn) 0 No activity — 0–15%
BE Ucb SA (UCB)
Pharmaceuticals & Medical Research Large (59.7bn) 0 No activity — 15–50%
NL argenx SE (ARGX)
Pharmaceuticals & Medical Research Large (57.8bn) -1–5 -$1M–$10M -0–15% —
US Cencora Inc (COR)
Healthcare Services Large (54.7bn) 1–5 $1M–$10M 0–15% 0–15%
Healthcare Services Large (50.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (47.7bn) 0 No activity — 0–15%
US Humana Inc (HUM)
Healthcare Services Large (45.1bn) 0 No activity — 0–15%
Healthcare Services Large (44.7bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Large (43.3bn) 1–5 $100K–$1M 0–15% 0–15%
US Seagen Inc (SGEN)
Pharmaceuticals & Medical Research Large (43.2bn) 0 No activity — 0–15%
Healthcare Services Large (43.1bn) 0 No activity — 0–15%
DE Bayer AG (BAYN)
Pharmaceuticals & Medical Research Large (41.8bn) 1–5 $1M–$10M 0–15% —
Pharmaceuticals & Medical Research Large (40.1bn) 0 No activity — 0–15%
GB Haleon PLC (HLN)
Pharmaceuticals & Medical Research Large (40.1bn) 1–5 $100K–$1M 0–15% 0–15%
Healthcare Services Large (39.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (39.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (38.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (37.7bn) -1–5 -$100K–$1M -0–15% 0–15%
US Waters Corp (WAT)
Healthcare Services Large (36.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (36.1bn) 0 No activity — 0–15%
US Zoetis Inc (ZTS)
Pharmaceuticals & Medical Research Large (34.1bn) 1–5 $100K–$1M 0–15% 0–15%
US Centene Corp (CNC)
Healthcare Services Large (32.1bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (32.0bn) 0 No activity — 50%+
CH Alcon AG (ALC)
Healthcare Services Large (30.8bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (30.5bn) 0 No activity — 0–15%
Healthcare Services Large (29.9bn) 0 No activity — 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals & Medical Research Large (29.8bn) 0 No activity — 0–15%
Healthcare Services Large (29.1bn) 1–5 $10M–$100M 50%+ 15–50%
US DexCom Inc (DXCM)
Healthcare Services Large (28.2bn) 0 No activity — 0–15%
US Cerner Corp (CERN)
Healthcare Services Large (27.9bn) 0 No activity — 0–15%
Healthcare Services Large (27.8bn) 6–10 $1M–$10M 0–15% 0–15%
US Resmed Inc (RMD)
Healthcare Services Large (27.0bn) 0 No activity — 0–15%
Healthcare Services Large (26.8bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (26.6bn) 0 No activity — 0–15%
US Illumina Inc (ILMN)
Healthcare Services Large (25.0bn) -1–5 -$100M+ -0–15% 0–15%
US Moderna Inc (MRNA)
Pharmaceuticals & Medical Research Large (24.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (24.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (23.9bn) -1–5 -$10M–$100M -0–15% 15–50%
US Steris Ltd (STE)
Healthcare Services Large (23.9bn) 0 No activity — 0–15%
DE Biontech SE (BNTX)
Pharmaceuticals & Medical Research Large (23.3bn) -1–5 -$1M–$10M -0–15% 50%+
Healthcare Services Large (23.2bn) 1–5 $1M–$10M 0–15% 15–50%
Pharmaceuticals & Medical Research Large (23.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (21.7bn) 0 No activity — 0–15%
US Incyte Corp (INCY)
Pharmaceuticals & Medical Research Large (21.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (21.4bn) 0 No activity — 0–15%
US Insmed Inc (INSM)
Pharmaceuticals & Medical Research Large (21.4bn) -1–5 -$1M–$10M -0–15% 0–15%
IE STERIS plc (STE)
Healthcare Services Large (20.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (20.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (20.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (18.9bn) -1–5 -$1M–$10M -0–15% 50%+
Healthcare Services Large (18.9bn) 1–5 $100K–$1M 0–15% 15–50%
US Viatris Inc (VTRS)
Pharmaceuticals & Medical Research Large (18.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (18.2bn) -11–20 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (17.9bn) 0 No activity — 50%+
Healthcare Services Large (17.4bn) -1–5 -$100K–$1M -0–15% 0–15%
US ABIOMED Inc (ABMD)
Healthcare Services Large (17.2bn) 0 No activity — 0–15%
US Hologic Inc (HOLX)
Healthcare Services Large (16.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (16.6bn) -6–10 -$1M–$10M -0–15% 0–15%
DK Genmab A/S (GMAB)
Pharmaceuticals & Medical Research Large (16.5bn) 0 No activity — —
Pharmaceuticals & Medical Research Large (16.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (16.0bn) 1–5 -$1M–$10M -0–15% 0–15%
IN Cipla Ltd (CIPLA)
Pharmaceuticals & Medical Research Large (15.9bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (15.7bn) 0 No activity — 50%+
Healthcare Services Large (15.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (15.1bn) -1–5 -$1M–$10M -0–15% 0–15%
FR Ipsen SA (IPN)
Pharmaceuticals & Medical Research Large (15.0bn) 0 No activity — 50%+
Healthcare Services Large (14.1bn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Large (14.0bn) 0 No activity — 0–15%